Unibest 优贝德
登录 / 注册

医药中间体

官方中间体全量目录 + 带 CEP / DMF / GMP / 冷链资质与产能明细的关键中间体 · 每条可发起 RFQ

查看原料药 API →

资质型关键中间体CEP / DMF / GMP / 冷链 / 产能 / 价格带明细

17
品名 / CAS纯度 / 杂质谱(脱敏)合成路线(脱敏)产能资质包装 / 冷链起订 / 价格带操作
Lenacapavir INT-1|N-Boc 手性胺酯
CAS 1620056-47-4 · Antivirals
靶点:lenacapavir
高保密
≥99.0%
单杂 ≤0.10%,总杂 ≤0.50%(脱敏)
手性还原 + Boc 保护(脱敏简述)1,200 kg/年
US DMF
5 kg / 25 kg 桶(铝箔袋内衬)
1 kg
US$ 2,600-3,800 / kg
Unibest Nantong cGMP Site
Lenacapavir INT-2|4-氯-7-硼酸酯吲唑
CAS 2189684-53-3 · Antivirals
靶点:lenacapavir
高保密
≥98.5%
有关物质谱见 CDA 资料室
吲唑构建 + Miyaura 硼化(脱敏简述)900 kg/年
US DMF
1 kg / 5 kg 铝瓶
冷链
0.5 kg
US$ 4,200-6,000 / kg
Unibest Nantong cGMP Site
Lenacapavir INT-3|环丙烷并环戊烷吡唑乙酸
CAS 1620056-83-8 · Antivirals
靶点:lenacapavir
高保密
≥99.0%
手性纯度 ≥99.5% ee(脱敏)
双环构建 + 三氟甲基化(脱敏简述)700 kg/年
US DMF
1 kg 铝瓶
冷链
0.5 kg
US$ 5,800-8,200 / kg
Unibest Nantong cGMP Site
Lenacapavir INT-4|3-甲基-3-(甲磺酰基)-1-丁炔
CAS 2109226-54-0 · Antivirals
靶点:lenacapavir
CDA 后可看
≥98.0%
单杂 ≤0.20%(脱敏)
炔基化 + 砜基引入(脱敏简述)2,400 kg/年
25 kg 桶
5 kg
US$ 780-1,150 / kg
Unibest Taizhou GMP-like Site
Lenacapavir (GS-6207) API
CAS 2189684-44-2 · Antivirals
靶点:lenacapavir
高保密
≥99.5%
单杂 ≤0.10%,总杂 ≤0.30%(脱敏)
汇聚式偶联 + 成盐(脱敏简述)300 kg/年
US DMFEU GMP
100 g / 1 kg 铝瓶(密闭系统)
冷链
100 g
🔒 CDA 后开放
Unibest Nantong cGMP Site
Doravirine INT-1|3-氯-5-[(吡啶基)氧基]苯甲腈
CAS 1155846-86-8 · Antivirals
靶点:doravirine
CDA 后可看
≥99.0%
单杂 ≤0.15%(脱敏)
芳香亲核取代成醚(脱敏简述)3,600 kg/年
US DMFEU GMP
25 kg 桶
10 kg
US$ 420-620 / kg
Qualified Partner — East China API Works
Doravirine INT-2|3-氯-5-碘苯酚
CAS 861347-86-6 · Antivirals
靶点:doravirine
≥99.0%
单杂 ≤0.15%(脱敏)
选择性碘代(脱敏简述)5,200 kg/年
25 kg 桶
25 kg
US$ 210-320 / kg
Qualified Partner — East China API Works
Entecavir INT-1|嘌呤核苷中间体
CAS 142217-80-9 · Antivirals
靶点:entecavir
≥99.0%
单杂 ≤0.10%(脱敏)
糖苷化 + 保护基策略(脱敏简述)1,800 kg/年
CEPUS DMFEU GMP
5 kg / 25 kg 桶
5 kg
US$ 1,150-1,700 / kg
Qualified Partner — East China API Works
Orforglipron INT-1|5-溴-4-氟-1-甲基吲唑
CAS 1784678-61-0 · GLP-1(代谢)
靶点:orforglipron
高保密
≥99.0%
单杂 ≤0.10%(脱敏)
吲唑环构建 + N-甲基化(脱敏简述)2,000 kg/年
US DMF
5 kg / 25 kg 桶
5 kg
US$ 1,850-2,600 / kg
Unibest Nantong cGMP Site
Orforglipron INT-2|(S)-4-甲基-1,3,2-二氧硫杂环戊烷-2,2-二氧化物
CAS 174953-30-1 · GLP-1(代谢)
靶点:orforglipron
高保密
≥99.0%
手性纯度 ≥99.5% ee(脱敏)
手性二醇环硫酸酯化(脱敏简述)1,500 kg/年
5 kg 桶
5 kg
US$ 980-1,450 / kg
Unibest Nantong cGMP Site
Orforglipron INT-3|(4-氟-3,5-二甲基苯基)肼盐酸盐
CAS 2212021-40-2 · GLP-1(代谢)
靶点:orforglipron
CDA 后可看
≥98.5%
单杂 ≤0.20%(脱敏)
重氮化还原(脱敏简述)3,000 kg/年
25 kg 桶
10 kg
US$ 560-820 / kg
Unibest Taizhou GMP-like Site
Orforglipron INT-4|(S)-3-氨基丁腈盐酸盐
CAS 1073666-54-2 · GLP-1(代谢)
靶点:orforglipron
CDA 后可看
≥99.0%
手性纯度 ≥99.5% ee(脱敏)
不对称合成 + 成盐(脱敏简述)2,200 kg/年
25 kg 桶
10 kg
US$ 640-950 / kg
Unibest Taizhou GMP-like Site
Belzutifan INT-1|(R)-3-氟-5-[(茚满酮基)氧基]苯甲腈
CAS 2738675-96-0 · Anti-cancer
靶点:belzutifan
高保密
≥99.0%
手性纯度 ≥99.5% ee(脱敏)
手性还原 + 成醚(脱敏简述)800 kg/年
US DMF
1 kg / 5 kg 铝瓶
1 kg
US$ 3,400-4,900 / kg
Unibest Taizhou GMP-like Site
Belzutifan INT-2|3-[(茚满酮基)氧基]-5-氟苯甲腈
CAS 1672665-55-2 · Anti-cancer
靶点:belzutifan
高保密
≥99.0%
单杂 ≤0.10%(脱敏)
成醚 + 砜基氧化(脱敏简述)1,100 kg/年
5 kg 桶
2 kg
US$ 2,100-3,100 / kg
Unibest Taizhou GMP-like Site
2'-dG(iBu) 亚磷酰胺单体
CAS 68892-42-2 · Nucleic Acids
靶点:oligonucleotide
≥99.0%
单杂 ≤0.10%(脱敏)
核苷保护 + 亚磷酰化(脱敏简述)400 kg/年
US DMFEU GMP
100 g / 1 kg 铝瓶
冷链
100 g
US$ 1,600-2,400 / 100g
Unibest Nantong cGMP Site
2'-dA(Bz) 亚磷酰胺单体
CAS 4546-72-9 · Nucleic Acids
靶点:oligonucleotide
≥99.0%
单杂 ≤0.10%(脱敏)
核苷保护 + 亚磷酰化(脱敏简述)400 kg/年
US DMFEU GMP
100 g / 1 kg 铝瓶
冷链
100 g
US$ 1,480-2,200 / 100g
Unibest Nantong cGMP Site
2'-dC(Bz) 亚磷酰胺单体
CAS 4836-13-9 · Nucleic Acids
靶点:oligonucleotide
≥99.0%
单杂 ≤0.10%(脱敏)
核苷保护 + 亚磷酰化(脱敏简述)350 kg/年
US DMFEU GMP
100 g / 1 kg 铝瓶
冷链
100 g
US$ 1,520-2,280 / 100g
Unibest Nantong cGMP Site

官方中间体全量目录含 CAS 号 · 按靶点 API 聚合

994 个中间体 · 覆盖 255 个靶点 API
中间体名称CAS 号对应靶点 API操作
(S)-2-Methylpyrrolidine-2-carboxylic acid hydrochloride1508261-86-6Nemorexant
1H-Benzimidazole, 6-chloro-7-methyl-2-[(2S)-2-methyl-2-pyrrolidinyl]-, hydrochloride (1:1)1788104-76-6Nemorexant
2-Iodo-5-methoxybenzoic acid54413-93-3Nemorexant
4-Chloro-3-Methylbenzene-1,2-diaMine hydrochloride1087743-89-2Nemorexant
5-methoxy-2-(2H-1,2,3-triazol-2-yl)benzoic acid1293284-55-5Nemorexant
6-Chloro-2,3-diaminotoluene673487-36-0Nemorexant
3-Chloro-4-[(pyridin-2-yl)methyloxy]aniline524955-09-7Neratinib/ Pyrotinib
6-amino-4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino) -7- ethoxyquinoline-3-carbonitrile848139-78-6Neratinib/ Pyrotinib
Methyl 5-acetaMido-2-aMino-4-ethoxybenzoate1222172-49-7Neratinib/ Pyrotinib
N-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl)848133-76-6Neratinib/ Pyrotinib
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline641571-11-1Nilotinib
3-[(Aminoiminomethyl)amino] -4-methylbenzoic acid ethyl ester mononitrate641569-96-2Nilotinib
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid641569-94-0Nilotinib
(3E)-2,3-Dihydro-3-(methoxyphenylmethylene) -2-oxo-1H-indole-6- carboxylic acid methyl ester1168150-46-6Nintedanib Esylate
2-Chloro-N-methyl-N-(4-nitrophenyl)acetamide2653-16-9Nintedanib Esylate
Methyl 2-oxoindole-6-carboxylate14192-26-8Nintedanib Esylate
N-(4-Aminophenyl)-N-methyl-2-(4-methylpiperazin -1-yl)acetamide262368-30-9Nintedanib Esylate
Trimethyl orthobenzoate707-07-3Nintedanib Esylate
(S)-tert-butyl 3-(4-aMinophenyl)piperidine-1-carboxylate1171197-20-8Niraparib
Methyl 3-formyl-2-nitrobenzoate138229-59-1Niraparib
Oxygen-fluorine acid82419-35-0Ofloxacin
1-(Cyclopropylcarbonyl)piperazine hydrochloride1021298-67-8Olaparib
2-fluoro-5-((4-oxo-3,4-dihydrophthalazin -1-yl)Methyl)benzoic acid763114-26-7Olaparib
2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]benzonitrile763114-25-6Olaparib
2-Fluoro-5-formylbenzonitrile218301-22-5Olaparib
3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid61260-15-9Olaparib
3-Methoxythiophene-2-carbaldehyde35134-07-7Oliceridine
OMadacycline (tosylate)1075240-43-5Omadacycline toslate
(2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate2212021-56-0Orforglipron
(4-Fluoro-3,5-dimethylphenyl)hydrazine hydrochloride2212021-40-2Orforglipron
(E)-3-(2-(methyl(phenyl)carbamoyl)-1H-indol-5-yl)acrylic acid3047292-97-4Orforglipron
(R,E)-N-methyl-5-(3-oxo-3-(2-oxo-4-phenyloxazolidin-3-yl)prop-1-en-1-yl)-N-phenyl-1H-indole-2-carboxamide3047293-00-2Orforglipron
(R)-4-Benzyl-2-oxazolidinone102029-44-7Orforglipron
(S)-3-Aminobutanenitrile Hydrochloride1073666-54-2Orforglipron
(S)-5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-N-methyl-N-phenyl-1H-indole-2-carboxamide2212021-79-7Orforglipron
1-(4-fluoro-1-methyl-1H-indazole-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-3-yl)-1,3-dihydro-2H-imidazole-2-one hydrochloride3036782-75-6Orforglipron
1-(cyanomethyl)-5-[(4S)-2,2-dimethyloxan-4-yl]-N-methyl-N-phenylindole-2-carboxamide2212021-80-0Orforglipron
1,3,2-Dioxathiolane, 4-Methyl-, 2,2-dioxide, (4R)-1006381-03-8Orforglipron
2H-Imidazol-2-one, 1-[(4S)-2-(4-fluoro-3,5- dimethylpheny1)-4,5,6,7-2H-Imidazol-2-one, 1-[(4S)-2- (4-fluoro-3,5-dimethylpheny1)-4,5,6,7-1H- indazol-5- yl)- 1,3-dihydro-2212022-56-3Orforglipron
3-(3-(4-fluoro-1-methyl-1H-indazole-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylic acid tert-butyl ester3036782-74-5Orforglipron
5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid2212021-83-3Orforglipron
5-Bromo-2-fluoro-m-xylene99725-44-7Orforglipron
5-Bromo-4-fluoro-1-methyl-1H-indazole1784678-61-0Orforglipron
5-bromo-N-methyl-N-phenyl-1H-indole-2-carboxamide2860499-50-7Orforglipron
5-Bromoindole-2-carboxylic acid7254-19-5Orforglipron
5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-(2,3-dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)-2212021-61-7Orforglipron
H-Indole-2-carboxamide, 1-[(1S,2S)-1-cyano-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-2212021-81-1Orforglipron
N-Boc-L-Alaninol79069-13-9Orforglipron
tert-buty1 (S)-3-amino-2-(4- fluoro-3,5- dimethylpheny1)-4- methyl-2,4,6,7-tetrahydro-5H-pyrazoloB ,3-c ]pyridine-5-carboxylate2212021-59-3Orforglipron
tert-butyl 2-(4-fluoro-3,5-dimethylphenyl)-3-(2-oxo-1H-imidazol-3-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxylate2212022-03-0Orforglipron
tert-butyl 3-amino-2-(4-fluoro-3,5-dimethylphenyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxylate2212021-41-3Orforglipron
1,4-BenzenediaMine, N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]-2-nitro-1421372-67-9OSIMERTINIB MESYLATE
3-(2-chloropyriMidin-4-yl)-1-Methylindole1032452-86-0OSIMERTINIB MESYLATE
4-fluoro-2-Methoxy-5-nitroaniline1075705-01-9OSIMERTINIB MESYLATE
4-Methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile675126-26-8OSIMERTINIB MESYLATE
5-hydroxy-4-methoxy-2-nitrobenzoic acid ethyl ester1146162-38-0OSIMERTINIB MESYLATE
N-(3-Chloropropyl)morpholine7357-67-7OSIMERTINIB MESYLATE
N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine1421372-94-2OSIMERTINIB MESYLATE
N,N,N'-Trimethylethylenediamine142-25-6OSIMERTINIB MESYLATE
N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]benzene-1,2,4-triamine1421372-66-8OSIMERTINIB MESYLATE